Experts back fish oil drug to prevent heart attack
COURTESY AMARIN
Capsules and packaging for the purified, prescription fish oil Vascepa.
WASHINGTON >> U.S. health advisers are recommending broader use of a prescription-strength fish oil drug to help prevent heart problems.
The non-binding recommendation paves the way for the Food and Drug Administration to expand the drug’s approval. That broader use could translate into billions in sales for drugmaker Amarin.
Currently, the drug is approved for a narrow group of patients with extremely high levels of a type of fat linked to heart disease.
Today’s recommendation was made by a panel of advisers to the FDA. The agency is expected to make a final decision on the drug before the end of the year.
0 Comments
By participating in online discussions you acknowledge that you have agreed to the Terms of Service. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. If your comments are inappropriate, you may be banned from posting. Report comments if you believe they do not follow our guidelines.
Having trouble with comments? Learn more here.
Please log in to comment
